Supplement Article

Posts about this type

The GABA Pathway and New Clinical Trial Data in MDD and PPD

March 16, 2023

Studies evaluating neuroactive steroid GABA-A receptor positive allosteric modulators demonstrate promising results for the treatment of MDD and PPD.

Kristina M. Deligiannidis, Anita H. Clayton

Supplement Article

Effective Management Approaches for Psychosis in Patients With Parkinson Disease

October 26, 2018

Are you familiar with diagnostic criteria for Parkinson disease psychosis (PDP)? Do you know which psychotic symptoms occur in the majority of patients with PD? Read this CME supplement...

Rajesh Pahwa, Daniel E. Kremens

Supplement Article

Binge-Eating Disorder and Comorbid Conditions: Differential Diagnosis and Implications for Treatment

January 25, 2017

Leslie Citrome

Supplement Article

Epidemiology and Recognition of Binge-Eating Disorder in Psychiatry and Primary Care

January 25, 2017

Susan G. Kornstein

Supplement Article

Pharmacologic Treatments for Binge-Eating Disorder

January 25, 2017

Susan L. McElroy

Supplement Article

Psychological and Behavioral Treatments for Binge-Eating Disorder

January 25, 2017

Carlos M. Grilo

DELETE Evaluating the Evidence

Injectable Antipsychotics in Schizophrenia

September 30, 2016

Read the recommendations of experts on the use of long-acting injectable antipsychotic medications in patients with schizophrenia.

Christoph U. Correll, Leslie Citrome, Peter M. Haddad, et al

Supplement Article

Pediatric Bipolar Disorder: Combination Pharmacotherapy, Adverse Effects, and Treatment of High-Risk Youth

September 15, 2016

Kiki D. Chang

Supplement Article

Diagnosis, Phenomenology, Differential Diagnosis, and Comorbidity of Pediatric Bipolar Disorder

September 15, 2016

Robert A. Kowatch

Supplement Article

Evidence-Based Family Interventions for Adolescents and Young Adults With Bipolar Disorder

September 15, 2016

David J. Miklowitz

Supplement Article

Evidence-Based Pharmacologic Treatment of Pediatric Bipolar Disorder

September 15, 2016

Robert L. Findling

Supplement Article

Evidence-Based Psychotherapies and Nutritional Interventions for Children With Bipolar Spectrum Disorders and Their Families

September 15, 2016

Mary A. Fristad

Supplement Article

Assessing Cognitive Impairment in Patients With Schizophrenia

February 24, 2016

S. Charles Schulz, Aimee Murray

Supplement Article

Behavioral and Emerging Pharmacologic Treatment Options for Cognitive Impairment in Schizophrenia

February 24, 2016

Sophia Vinogradov, S. Charles Schulz

Supplement Article

Impact of Cognitive and Social Cognitive Impairment on Functional Outcomes in Patients With Schizophrenia

February 24, 2016

Michael F. Green

Supplement Article

Assessing the Risk Factors for Difficult-to-Treat Depression and Treatment-Resistant Depression

January 27, 2016

Bradley Gaynes

Supplement Article

Identifying Patients With Depression Who Require a Change in Treatment and Implementing That Change

January 27, 2016

George I. Papakostas

Supplement Article

Implementing Treatment Strategies for Different Types of Depression

January 27, 2016

Roger S. McIntyre

Supplement Article

Managing Medical Comorbidities in Patients With Depression to Improve Prognosis

January 27, 2016

Michael E. Thase

DELETE Understanding the Lifetime Course of Schizophrenia

The Early Longitudinal Course of Cognitive Deficits in Schizophrenia

June 5, 2014

Keith H. Nuechterlein, Joseph Ventura, Kenneth L. Subotnik, et al

DELETE Understanding the Lifetime Course of Schizophrenia

What Is the Evidence for Changes in Cognition and Functioning Over the Lifespan in Patients With Schizophrenia?

June 5, 2014

Philip D. Harvey

DELETE Understanding the Lifetime Course of Schizophrenia

The Longitudinal Course of Cognitive Impairment in Schizophrenia: An Examination of Data From Premorbid Through Posttreatment Phases of Illness

June 5, 2014

Richard S. E. Keefe

DELETE Understanding the Lifetime Course of Schizophrenia

Patient Outcomes Within Schizophrenia Treatment: A Look at the Role of Long-Acting Injectable Antipsychotics

June 5, 2014

Rimal B. Bera

DELETE Understanding the Lifetime Course of Schizophrenia

Schizophrenia: From Genetics to Biology to Predictive Medicine

June 5, 2014

Alexander B. Niculescu III

1 2 3 … 5 »

Supplement Article

The GABA Pathway and New Clinical Trial Data in MDD and PPD

Effective Management Approaches for Psychosis in Patients With Parkinson Disease

Binge-Eating Disorder and Comorbid Conditions: Differential Diagnosis and Implications for Treatment

Epidemiology and Recognition of Binge-Eating Disorder in Psychiatry and Primary Care

Pharmacologic Treatments for Binge-Eating Disorder

Psychological and Behavioral Treatments for Binge-Eating Disorder

Injectable Antipsychotics in Schizophrenia

Pediatric Bipolar Disorder: Combination Pharmacotherapy, Adverse Effects, and Treatment of High-Risk Youth

Diagnosis, Phenomenology, Differential Diagnosis, and Comorbidity of Pediatric Bipolar Disorder

Evidence-Based Family Interventions for Adolescents and Young Adults With Bipolar Disorder

Evidence-Based Pharmacologic Treatment of Pediatric Bipolar Disorder

Evidence-Based Psychotherapies and Nutritional Interventions for Children With Bipolar Spectrum Disorders and Their Families

Assessing Cognitive Impairment in Patients With Schizophrenia

Behavioral and Emerging Pharmacologic Treatment Options for Cognitive Impairment in Schizophrenia

Impact of Cognitive and Social Cognitive Impairment on Functional Outcomes in Patients With Schizophrenia

Assessing the Risk Factors for Difficult-to-Treat Depression and Treatment-Resistant Depression

Identifying Patients With Depression Who Require a Change in Treatment and Implementing That Change

Implementing Treatment Strategies for Different Types of Depression

Managing Medical Comorbidities in Patients With Depression to Improve Prognosis

The Early Longitudinal Course of Cognitive Deficits in Schizophrenia

What Is the Evidence for Changes in Cognition and Functioning Over the Lifespan in Patients With Schizophrenia?

The Longitudinal Course of Cognitive Impairment in Schizophrenia: An Examination of Data From Premorbid Through Posttreatment Phases of Illness

Patient Outcomes Within Schizophrenia Treatment: A Look at the Role of Long-Acting Injectable Antipsychotics

Schizophrenia: From Genetics to Biology to Predictive Medicine

ELSEWHERE:

FOLLOW US:

Supplement Article

Posts about this type

The GABA Pathway and New Clinical Trial Data in MDD and PPD

Effective Management Approaches for Psychosis in Patients With Parkinson Disease

Binge-Eating Disorder and Comorbid Conditions: Differential Diagnosis and Implications for Treatment

Epidemiology and Recognition of Binge-Eating Disorder in Psychiatry and Primary Care

Pharmacologic Treatments for Binge-Eating Disorder

Psychological and Behavioral Treatments for Binge-Eating Disorder

Injectable Antipsychotics in Schizophrenia

Pediatric Bipolar Disorder: Combination Pharmacotherapy, Adverse Effects, and Treatment of High-Risk Youth

Diagnosis, Phenomenology, Differential Diagnosis, and Comorbidity of Pediatric Bipolar Disorder

Evidence-Based Family Interventions for Adolescents and Young Adults With Bipolar Disorder

Evidence-Based Pharmacologic Treatment of Pediatric Bipolar Disorder

Evidence-Based Psychotherapies and Nutritional Interventions for Children With Bipolar Spectrum Disorders and Their Families

Assessing Cognitive Impairment in Patients With Schizophrenia

Behavioral and Emerging Pharmacologic Treatment Options for Cognitive Impairment in Schizophrenia

Impact of Cognitive and Social Cognitive Impairment on Functional Outcomes in Patients With Schizophrenia

Assessing the Risk Factors for Difficult-to-Treat Depression and Treatment-Resistant Depression

Identifying Patients With Depression Who Require a Change in Treatment and Implementing That Change

Implementing Treatment Strategies for Different Types of Depression

Managing Medical Comorbidities in Patients With Depression to Improve Prognosis

The Early Longitudinal Course of Cognitive Deficits in Schizophrenia

What Is the Evidence for Changes in Cognition and Functioning Over the Lifespan in Patients With Schizophrenia?

The Longitudinal Course of Cognitive Impairment in Schizophrenia: An Examination of Data From Premorbid Through Posttreatment Phases of Illness

Patient Outcomes Within Schizophrenia Treatment: A Look at the Role of Long-Acting Injectable Antipsychotics

Schizophrenia: From Genetics to Biology to Predictive Medicine

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles